A Phase 1 Study of ADI-001 in Lupus Nephritis

Conditions: Lupus Nephritis; Autoimmune Diseases Interventions: Drug: ADI-001; Drug: Fludarabine; Drug: Cyclophosphamide Sponsors: Adicet Bio, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials